Robins Kaplan LLP® announced today that Eamon O’Kelly has joined the firm’s Antitrust and Trade Regulation Group as of counsel in the firm’s New York office.
“Eamon’s depth of experience as an accomplished antitrust litigator combined with his background as a trusted regulatory advisor on competition issues will further enhance the capabilities of our growing antitrust practice in New York,” said Hollis Salzman, co-chair of Robins Kaplan’s Antitrust and Trade Regulation Group and assistant managing partner of the New York office. “His work successfully defending Fortune 100 companies in complex antitrust litigation fits in well with our strategy to provide a breadth of perspective to our clients on both sides of the courtroom.”
Mr. O’Kelly previously led the nationwide antitrust practices of Arent Fox and Dewey & LeBoeuf where he defended large publicly traded companies in “bet the company” litigation under the Sherman Act, Racketeer Influenced and Corrupt Organizations Act, and Federal Trade Commission Act, among other statutes. His frequent cross-border work has included class actions arising out of European Commission cartel investigations and numerous international arbitrations. In addition to his work as a litigator, he counsels clients on regulatory issues in connection with mergers and acquisitions, pricing and distribution, and anti-bribery laws.
Full Content: Business Wire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas